 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 12/04/2023 |
$20.12 |
$20.84 |
$19.81 |
$20.84 |
653.30K | | 12/05/2023 |
$20.52 |
$20.98 |
$20.23 |
$20.82 |
651.80K | | 12/06/2023 |
$20.95 |
$21.15 |
$20.58 |
$20.85 |
630.90K | | 12/07/2023 |
$20.88 |
$21.22 |
$20.51 |
$20.89 |
621.30K | | 12/08/2023 |
$20.76 |
$20.95 |
$19.98 |
$20.01 |
779.30K |
|
|
| Sage Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines with the potential to transform the lives of people with debilitating disorders of the brain. Co.'s principal product, ZULRESSO, is a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. Co.'s other product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder, and PPD. Co. has a portfolio of other compounds that target GABAA receptors, including SAGE-324. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing. | |
|
Sage Therapeutics (SAGE) has the following price history information. Looking back at SAGE historical stock prices for the last five trading days, on December 04, 2023, SAGE opened at $20.12, traded as high as $20.84 and as low as $19.81, and closed at $20.84. Trading volume was a total of 653.30K shares. On December 05, 2023, SAGE opened at $20.52, traded as high as $20.98 and as low as $20.23, and closed at $20.82. Trading volume was a total of 651.80K shares. On December 06, 2023, SAGE opened at $20.95, traded as high as $21.15 and as low as $20.58, and closed at $20.85. Trading volume was a total of 630.90K shares. On December 07, 2023, SAGE opened at $20.88, traded as high as $21.22 and as low as $20.51, and closed at $20.89. Trading volume was a total of 621.30K shares. On December 08, 2023, SAGE opened at $20.76, traded as high as $20.95 and as low as $19.98, and closed at $20.01. Trading volume was a total of 779.30K shares.
SAGE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sage Therapeutics shares, starting with a $10,000 purchase of SAGE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/21/2014 |
|
| End date: |
12/08/2023 |
|
| Start price/share: |
$30.00 |
|
| End price/share: |
$20.01 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-33.30% |
|
| Average Annual Total Return: |
-4.22% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,670.96 |
|
| Years: |
9.39 |
|
|
|
| Date |
Close |
| 12/04/2023 | $20.84 | | 12/05/2023 | $20.82 | | 12/06/2023 | $20.85 | | 12/07/2023 | $20.89 | | 12/08/2023 | $20.01 |
|
|
Free SAGE Email Alerts:
